Classes
- Chemistry and biochemistry AB01098 | First Faculty of Medicine
- Biochemistry and Metabolism +1B01691 | First Faculty of Medicine
- Chemistry and Biochemistry +3B01753 | First Faculty of Medicine
- Patobiochemistry 2 - Molecular Oncology +1B02432 | First Faculty of Medicine
- Pathobiochemistry 2 - Molecular Oncology +1B82432 | First Faculty of Medicine
- Medical Chemistry and BiochemistryB83120 | First Faculty of Medicine
Publications
- Inhibition of multifunctional dipeptidyl peptidase-IV: is there a risk of oncological and immunological adverse effects?2010 | First Faculty of Medicine
- Leukocytic Elastase and its Inhibition in Some Tissues of the Oral Cavity2001 | First Faculty of Medicine
- Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells2024 | First Faculty of Medicine
- Erlebašské rozjímání 5. Co je člověk?2023 | First Faculty of Medicine, Faculty of Science, Catholic Theological Faculty
- Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours2023 | First Faculty of Medicine
- Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting2023 | First Faculty of Medicine
- Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation2022 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Science, Faculty of Medicine in Hradec Králové
- Erlebašské rozjímání 4 : Dar života2022 | First Faculty of Medicine, Faculty of Science, Hussite Theological Faculty
- Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?2022 | First Faculty of Medicine
- New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity2022 | First Faculty of Medicine
Loading network view...